Frontlight ResearchEarly access
Taking peopleNo phase
Hypothermia Versus Normothermia After Extracorporeal Cardiopulmonary Resuscitation for Out-of-hospital Cardiac Arrest
Key facts
- Who runs it
- Kagawa University
- Where
- Japan29 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 468 people, planned
- Started
- 6 Jan 2025
- Expected to end
- 31 Jan 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Temperature control
- Record updated
- 7 August 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- OHCA
- Age of 18-75 years, known or estimated
- An initial cardiac arrest rhythm of ventricular fibrillation/pulseless ventricular tachycardia or pulseless electrical activity
Who cannot take part
- Do Not Attempt Resuscitation) order confirmed prior to temperature control
- Concomitant illness, such as malignancy, shortens life expectancy (180-day survival unlikely)
- OHCA of presumed non-cardiac etiology
- Surgical intervention before temperature control (e.g., surgical intervention for the primary disease or complications related to resuscitation/ECMO procedures)
- Known cerebral performance category (CPC) of 3-4 before cardiac arrest
- Known chronic obstructive pulmonary disease with home oxygen therapy
- ECMO initiated after sustained return of spontaneous circulation (ROSC) and patients with sustained ROSC before ECMO initiation
- Time from emergency call or witnessed arrest to hospital arrival of >60 min
- Time from hospital arrival to ECMO initiation of >60 min
- Pre-hospital ECPR
- Unavailability of the ECMO heat exchanger for temperature control
- Glasgow Coma Scale score before temperature control of >8
- Core body temperature upon hospital arrival of ≤32ºC
- Limitations in intensive care before temperature control
- Known or suspected pregnancy
- Consent not obtained or withdrawn by the participant or surrogate
- Other reasons, physician's decision not to enroll the patient
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The SAVE-J NEUROTHERM trial is a cluster randomized trial that evaluated and compared the mortality risk, neurological outcomes, and adverse events between patients who underwent hypothermia and those who underwent normothermia after extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest.
The 2 groups in the trial
- NormothermiaExisting treatment, for comparison
Temperature control at 36 °C
Treatment: Temperature control
- HypothermiaTreatment being tested
Temperature control at 33-34 °C
Treatment: Temperature control
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Hypothermia Versus Normothermia After Extracorporeal Cardiopulmonary Resuscitation for Out-of-hospital Cardiac Arrest: A Cluster Randomized Trial (SAVE-J NEUROTHERM Trial)
- Criteria questions
- Built from NCT06776549, who can take part
- Record updated
- 7 August 2026